These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 3516892

  • 1. Ceftazidime in patients with severe Pseudomonas infections.
    Lechi A, Arosio E, Montesi G, Vaona B, Ghidini O, Parrinello E.
    Int J Clin Pharmacol Ther Toxicol; 1986 Mar; 24(3):159-64. PubMed ID: 3516892
    [Abstract] [Full Text] [Related]

  • 2. [Evaluation of ceftazidime monotherapy in Pseudomonas aeruginosa bacteremias. Prospective study].
    Gómez J, Moldenhauer F, Ruiz J, Redondo C, Alonso JM, Canteras M, Sánchez-Gascón F.
    Med Clin (Barc); 1989 Sep 16; 93(7):249-51. PubMed ID: 2682060
    [Abstract] [Full Text] [Related]

  • 3. [In vitro sensitivity of 39 strains of Pseudomonas aeruginosa isolated from urine culture of hospitalized patients].
    Vanni M, Zucca C.
    Minerva Med; 1986 Jun 30; 77(27):1289-92. PubMed ID: 3088493
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Urinary tract infection. Diabetics and non-diabetic patients.
    Akbar DH.
    Saudi Med J; 2001 Apr 30; 22(4):326-9. PubMed ID: 11331489
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The efficacy and safety of isepamicin and ceftazidime compared with amikacin and ceftazidime in acute lower respiratory tract infection.
    Colardyn F.
    J Chemother; 1995 Jun 30; 7 Suppl 2():129-35. PubMed ID: 8622101
    [Abstract] [Full Text] [Related]

  • 10. Use of ceftazidime in severe Gram-negative infections--a preliminary study.
    Clumeck N, Vanlaethem Y, Gordts B, Jaspar N, Butzler JP.
    J Antimicrob Chemother; 1981 Sep 30; 8 Suppl B():317-21. PubMed ID: 19803007
    [Abstract] [Full Text] [Related]

  • 11. [Cefotaxime in septicaemia and severe infections due to multiresistant Gram-negative bacilli (author's transl)].
    Dureux JB, Canton P, Roche G, Weber M, Gérard A.
    Nouv Presse Med; 1981 Feb 26; 10(8):601-6. PubMed ID: 6259602
    [Abstract] [Full Text] [Related]

  • 12. Cefsulodin and ceftazidime, two antipseudomonal cephalosporins.
    Smith BR.
    Clin Pharm; 1984 Feb 26; 3(4):373-85. PubMed ID: 6380902
    [Abstract] [Full Text] [Related]

  • 13. Surveillance of antimicrobial susceptibility of urinary pathogens in a tertiary care hospital.
    Arya SC, Agarwal N, Agarwal S.
    Singapore Med J; 2007 Mar 26; 48(3):270-1; author reply 271. PubMed ID: 17342301
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Ceftazidime in the treatment of Pseudomonas infections in intensive-care patients.
    Rondanelli R, Dionigi RV, Regazzi MB, Maurelli M, Calvi M, Mapelli A.
    Int J Clin Pharmacol Ther Toxicol; 1986 Sep 26; 24(9):457-9. PubMed ID: 3536763
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Evaluation of area under the inhibitory curve (AUIC) and time above the minimum inhibitory concentration (T>MIC) as predictors of outcome for cefepime and ceftazidime in serious bacterial infections.
    McKinnon PS, Paladino JA, Schentag JJ.
    Int J Antimicrob Agents; 2008 Apr 26; 31(4):345-51. PubMed ID: 18313273
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.